Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Transplant Cell Ther. 2021 Jan 15;27(4):352.e1–352.e5. doi: 10.1016/j.jtct.2021.01.009

Table 2.

SAEs in Peripheral Blood Apheresis Donors

Age (yr) Gender Race BMI (Category) NMDP URD Comorbid Condition Group. Donation no. Timing of SAE(d)* GCSF dose/day (μg/kg) GCSF (days) Cumulative Apheresis Blood Volume (L) Apheresis Duration (d) CVAD Expected? Related? SAE Description and CTCAE Grade
69 M W 32.5 (Obese) CV: Defer 1st 2 12.2 5 60 3 Yes Yes Definite Thrombocytopenia.
Hospitalized. Recovered.
CTCAE 3
54 F W 40.3 (Obese) CV: Accept/Defer unknown 1st −1 7.1 3 30 1 No No Probable Pneumonitis. Possibly due to GCSF. Recovered.
CTCAE 3.
57 M W 26.5 (Overweight) CV: Accept 1st 0 10.5 5 23.1 2 No Yes Probable Vasovagal syncope with hypotension and bradycardia.
Recovered after IV fluids.
CTCAE 4.
34 F API 23.2 (Normal) Hemorrhage requiring medical attention: GI: Accept 2nd −3 10.72 6 24.5 2 Yes No Possible Upper GI bleed. Gastric ulcer documented by EGD. History of prior GI bleed.
Recovered.
CTCAE 4
52 F W 28.1 (Overweight) CNS/Psych: Defer 1st 11 18.1 5 24 2 Yes No Probable Hospitalized for observation of liver test abnormalities and elevated WBC.
Recovered.
CTCAE Unknown.
41 F W 49.9 (Obese) CV; Psych: Accept/Defer unknown 1st 0 8.1 6 30 2 Yes No Probable Supraventricular tachycardia during apheresis.
Hospitalization for heart rate control.
Prior history of tachycardia
Recovered.
CTCAE 4
63 M W 32.3 (Obese) None: Accept 1st 2 10 6 15 1 No No Possible Orthopnea and hypoxemia 2 days after collection.
CT chest. EKG without significant findings.
Orthopnea resolved on day 3 post collection.
CTCAE 3

API indicates Asian/Pacific Islander; CVAD, central venous access device; WBC, white blood cell count; CT, computed tomography.

*

Days before or after initiation of hematopoietic cell collection.

Based on NMDP unrelated donor guidelines, more information would be needed to determine whether to accept or defer.